Search

Wednesday's Fireside Chat: Financing Innovation & Doing Social Good

WEDNESDAY'S FIRESIDE CHAT: FINANCING INNOVATION & DOING SOCIAL GOOD

Massachusetts' biopharma industry is arguably the strongest in the world. That is due in large part to the successful cooperation of...

New Study Shows Strong Interest in China Partnerships

NEW STUDY SHOWS STRONG INTEREST IN CHINA PARTNERSHIPS

A new report suggests that biopharmaceutical companies are expressing strong interest in the Chinese marketplace. “Heading East: Biopharma...

 
 
 

DENOVO BIOPHARMA TO PARTICIPATE AT MORGAN STANLEY 4TH ANNUAL CHINA SUMMIT

SAN DIEGO, May 29, 2018 /PRNewswire/ - Denovo Biopharma LLC, a pioneer in using precision medicine to develop innovative therapies,...

 
 
 
 
 
 

LATEST UP AND COMING GENE THERAPIES

Posted on: 8 May 2018, Gene therapy's numbers look promising. In a year full of biopharma mergers and acquisitions, one of the biggest...

KINIKSA AND SCHOLAR ROCK GUN FOR $175M IPOS AS TWO OTHER BIOTECHS STRUGGLE

It was something of an up-and-down week for IPOs: Two biotechs, Alzheimer's-focused Alzheon and brittle bone drug company Mereo BioPharma...

 
 
 

ACCOUNTING ASSOCIATE - DENOVO BIOPHARMA - SAN DIEGO, CA

*POSITION SUMMARY: * Under general guidance by the CFO, the Accounting Associate will perform general clerical functions to support...

Agenda Posted for Xconomy's What's Hot in Boston Biotech on May 16

AGENDA POSTED FOR XCONOMY'S WHAT'S HOT IN BOSTON BIOTECH ON MAY 16

Join Xconomy next month for our sixth installment of What's Hot in Boston Biotech on May 16 at the Broad Institute of MIT and Harvard....

 
 
 
Bio Roundup: CMS Backs Cancer Tests, Right to Try Passes, AbbVie Sinks

BIO ROUNDUP: CMS BACKS CANCER TESTS, RIGHT TO TRY PASSES, ABBVIE SINKS

We'll start this week's roundup with several stories from Washington, D.C. that could have a lasting effect on public health. The FDA...

 
 
 
Join Xconomy as We Bring Back the NY Biotech Expats on June 21

JOIN XCONOMY AS WE BRING BACK THE NY BIOTECH EXPATS ON JUNE 21

Here's a question posed time and again by the those toiling away to build up New York's biotech scene : What if we could just bring...

Alder BioPharma's Schatzman Steps Down as CEO by “Mutual Decision”

ALDER BIOPHARMA'S SCHATZMAN STEPS DOWN AS CEO BY “MUTUAL DECISION”

Alder BioPharmaceuticals is now looking for a new chief executive, just as the company readies plans to file for FDA approval of its...

 
 
 

IS TECH MONEY BAD FOR BUSINESS? SILICON VALLEY CASH MAKES SOME BIOPHARMA VCS BRISTLE, OTHERS CHEER

Bioregnum The view from Brittany Meiling The emergence of new players dabbling in biopharma money has been the subject of giddy observations...

 
 
 

FDA GRANTS YISHENG BIOPHARMA'S CLINICAL TREATMENT ITS SECOND ORPHAN DRUG DESIGNATION

Beijing-based Yisheng Biopharma Co. is celebrating this morning after its lead immunology treatment snagged a second Orphan Drug Designation...

BIOPHARMA MARKETING ASSOCIATE

Reveal Biosciences is leading the application of artificial intelligence to computational pathology and advanced tissue technologies....

 
 
 
The biopharma companies that could be getting ready to spend big following tax reform

THE BIOPHARMA COMPANIES THAT COULD BE GETTING READY TO SPEND BIG FOLLOWING TAX REFORM

Reuters As part of tax reform, pharmaceutical and biotech companies are likely to bring back billions in cash to the US. What these...

3 BIOPHARMAS INVESTORS SHOULD KEEP THEIR EYE ON IN 2018

As we start the New Year, here is a look at three drug stocks that look well-positioned for 2018 and are witnessing upward estimate...